Patents Assigned to SciSparc Ltd.
  • Publication number: 20220211647
    Abstract: The present disclosure provides pharmaceutical compositions and methods for treating paracetamol amenable conditions, such as pain and fever. The pharmaceutical compositions comprise certain combinations of derivatives of 4-Aminophenols and N-acylethanolamines. Also disclosed are methods and kits for treating or minimizing paracetamol amenable conditions.
    Type: Application
    Filed: April 22, 2020
    Publication date: July 7, 2022
    Applicant: SCISPARC LTD.
    Inventors: Ascher SHMULEWITZ, Adi ZULOFF-SHANI, Ephraim BRENER
  • Publication number: 20220071949
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Applicant: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20220071948
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Applicant: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Patent number: 11234956
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: February 1, 2022
    Assignee: SciSparc Ltd.
    Inventors: Ascher Shmulewitz, Elran Haber, Ephraim Brener
  • Patent number: 11207290
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: December 28, 2021
    Assignee: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20210393577
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 23, 2021
    Applicant: SciSparc Ltd.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER
  • Patent number: 11197845
    Abstract: The present invention provides pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: December 14, 2021
    Assignee: SciSparc Ltd.
    Inventors: Ephraim Brener, Elran Haber, Ascher Shmulewitz
  • Publication number: 20210177779
    Abstract: The present invention provides pharmaceutical compositions comprising opioids and N-acylethanolamines, and methods for their use in preventing and treating a variety of opioid-responsive conditions and opioid-related side-effects.
    Type: Application
    Filed: November 27, 2020
    Publication date: June 17, 2021
    Applicant: SciSparc Ltd.
    Inventors: Ascher SHMULEWITZ, Elran HABER, Ephraim BRENER